NCT02210468View on ClinicalTrials.gov

APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

December 31, 2016

Conditions
PainOsteoarthritis
Interventions
DEVICE

APIC-CF, 4 cc

DEVICE

APIC-CF, 2 cc

OTHER

Placebo Comparator: Saline

Placebo Comparator: Saline

Trial Locations (1)

21204

RECRUITING

IRC Clinical, Townsend

Sponsors
All Listed Sponsors
lead

Cytonics Corporation

INDUSTRY